Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

about

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events.

P2860

Q55014809-6CF88A00-57D3-426E-8B6A-8AAC6983362D

P2860

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

Item

http://www.wikidata.org/entity/Q55055702

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Periprocedural anticoagulation ...... al cardioversion and ablation.

@en

Periprocedural anticoagulation ...... al cardioversion and ablation.

@nl

type

Item

label

Periprocedural anticoagulation ...... al cardioversion and ablation.

@en

Periprocedural anticoagulation ...... al cardioversion and ablation.

@nl

prefLabel

Periprocedural anticoagulation ...... al cardioversion and ablation.

@en

Periprocedural anticoagulation ...... al cardioversion and ablation.

@nl

P1476

Periprocedural anticoagulation ...... al cardioversion and ablation.

@en

P2093

M A Brouwer

http://www.w3.org/2001/XMLSchema#string

S P G van Vugt

http://www.w3.org/2001/XMLSchema#string

P2860

Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.

Atrial stunning: basics and clinical considerations.

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted

Cardioversion Of Atrial Fibrillation And Oral Anticoagulation.

P2888

s12471-018-1119-z

P31

scholarly article

P356

10.1007/S12471-018-1119-Z

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103909540

http://www.w3.org/2001/XMLSchema#string

P698

29744816

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation

P932

5968006

http://www.w3.org/2001/XMLSchema#string

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

about

P2860

P2860

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921

P932